Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Myocarditis III: Medical Management

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...

Myocarditis I: Introduction

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...

Myocarditis IV: Nursing Management

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...

Pericarditis I: Introduction

Pericarditis I: Introduction

Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...

Pericarditis III: Medical Management

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The nuclear receptor ROR-alpha is a critical myogenic regulator of the cardiomyocyte transcriptome, including the alpha-1A adrenergic receptor.

bioRxiv : the preprint server for biology·2026

Same author

Effect of pillow on pain, disability and sleep quality in patients with chronic neck pain: A systematic review.

Rehabilitacion·2025

Same author

Interleukin-18 cytokine gene polymorphism 137G/C (rs187238) and susceptibility to tuberculosis in north India.

Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace·2025

Same author

Prevalence of human metapneumovirus infection among children suffering from acute respiratory illness in India: a systematic review and meta-analysis.

Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace·2025

Same author

Effect of high flow nasal cannula <i>versus</i> conventional nasal cannula oxygen therapy in patients undergoing endobronchial ultrasound-guided transbronchial needle aspiration.

Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace·2025

Same author

Common epidermal growth factor receptor mutations in north Indian patients with non-small cell lung carcinoma: evidence from real-time polymerase chain reaction.

Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace·2024

Same journal

Response to letter from Mr. Yudai Kaneda entitled "Patient Preference and Generalisability in a Trial of Cheek Acupuncture for Stress Urinary Incontinence" (QJM-2026-999).

QJM : monthly journal of the Association of Physicians·2026

Same journal

Trends in mortality of people on dialysis in England and Wales over the last 15 years.

QJM : monthly journal of the Association of Physicians·2026

Same journal

Familial pulmonary fibrosis due to pathogenic TERT variant presenting with a UIP-PPFE phenotype.

QJM : monthly journal of the Association of Physicians·2026

Same journal

Corkscrew Oesophagus Due to Distal Oesophageal Spasm.

QJM : monthly journal of the Association of Physicians·2026

Same journal

Correction to: Integrated care management for patients following acute stroke: a systematic review.

QJM : monthly journal of the Association of Physicians·2026

Same journal

Methodological concerns regarding blinding and long term efficacy of fire needle therapy for plaque psoriasis.

QJM : monthly journal of the Association of Physicians·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Oct 1, 2025

Simultaneous 3D Analysis of Cardiac Damage and Immune Response in Reperfused Acute Myocardial Infarction Using Light Sheet Fluorescence Microscopy

Simultaneous 3D Analysis of Cardiac Damage and Immune Response in Reperfused Acute Myocardial Infarction Using Light Sheet Fluorescence Microscopy

Published on: September 26, 2025

Myocarditis post-SARS-CoV-2 vaccination: a systematic review.

M Goyal¹, I Ray², D Mascarenhas¹

¹From the Department of Neonatology, Seth GSMC & KEMH, Acharya Donde Marg, Parel East, Parel, Mumbai, Maharashtra 400012, India.

QJM : Monthly Journal of the Association of Physicians

|March 3, 2022

Summary

This summary is machine-generated.

Myocarditis after COVID-19 vaccination is typically mild, predominantly affecting young males and resolving quickly with conservative treatment. This highlights the need for standardized myocarditis definitions and treatment guidelines.

More Related Videos

Aggravation of Myocardial Ischemia upon Particulate Matter Exposure in Atherosclerosis Animal Model

Aggravation of Myocardial Ischemia upon Particulate Matter Exposure in Atherosclerosis Animal Model

Published on: December 10, 2021

Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells

Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells

Published on: August 17, 2022

Related Experiment Videos

Last Updated: Oct 1, 2025

Simultaneous 3D Analysis of Cardiac Damage and Immune Response in Reperfused Acute Myocardial Infarction Using Light Sheet Fluorescence Microscopy

Simultaneous 3D Analysis of Cardiac Damage and Immune Response in Reperfused Acute Myocardial Infarction Using Light Sheet Fluorescence Microscopy

Published on: September 26, 2025

Aggravation of Myocardial Ischemia upon Particulate Matter Exposure in Atherosclerosis Animal Model

Aggravation of Myocardial Ischemia upon Particulate Matter Exposure in Atherosclerosis Animal Model

Published on: December 10, 2021

Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells

Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells

Published on: August 17, 2022

Area of Science:

Cardiology
Vaccinology
Public Health

Background:

Myocarditis following coronavirus disease 2019 (COVID-19) vaccination presents with variable clinical criteria and treatment approaches globally.
A systematic review was necessary to understand the clinical characteristics, diagnostic parameters, therapeutic interventions, and outcomes of post-COVID-19 vaccination myocarditis.

Approach:

A systematic review was conducted, analyzing 85 articles comprising 2184 patients diagnosed with myocarditis post-COVID-19 vaccination.
Data were extracted from electronic databases including MEDLINE, EMBASE, PubMed, and Web of Science.
PROSPERO registration ensured systematic and transparent methodology.

Key Points:

The study population was predominantly young males (73.4%, mean age 25.5 years), with 99.4% receiving mRNA vaccines.
Common symptoms included chest pain (90.1%), dyspnea (25.7%), and fever (11.9%), with elevated CRP (83.3%) and troponin (97.6%) observed.
Treatment primarily involved NSAIDs (76.5%), steroids (14.1%), and colchicine (7.3%), with a low mortality rate (0.46%).

Conclusions:

Myocarditis post-COVID-19 vaccination is generally mild, frequently observed in young, healthy males, and typically resolves rapidly with conservative management.
The findings underscore the need for harmonized case definitions and definitive treatment guidelines for this adverse event.
Further research is recommended to refine understanding and management strategies for vaccine-associated myocarditis.